Symtomax has created its very own CBD oral tab as a novel and innovative delivery form for cannabinoids. Over the last few years the global market for cannabidiol (CBD) has expanded rapidly with growing demand for CBD products expected to continue through 2022 – transforming this market into a mega industry of its own. According to the latest research by the Global Wellness Institute (GWI), the worldwide wellness market grew 12.9% from ... Read More
Discover how the Porto based medical cannabis company, Symtomax, is poised to conquer the European market and beyond.Symtomax based in Porto, Portugal are licenced to cultivate, import and export medical cannabis SativaL, with their facility that includes indoor, outdoor and greenhouse cultivation, research and quality control labs as well as processing, packaging and distribution for medical cannabis and cannabinoid-containing products, totalling 105 hectares with 95 hectares approved for cultivation ... Read More
Symtomax is pleased to announce the appointment of Dr Eurico Castro Alves, former State Secretary for Health and President of Portugal’s health regulator Infarmed as director of Symtomax. The appointment highlights Symtomax’s plans to grow the company into a major player in the European Medical Cannabis market. “We welcome Dr Eurico, like Symtomax he is passionate about healthcare, his appointment brings experience and unique expertise at the highest level, and ... Read More
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.